SCHEMBL4979970

SCHEMBL4979970

Cc1ccc2c(c1)C1(NC(=O)N(CCC(C)C)C1=O)C(=O)N2

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 3/20 0.41
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ADAMTS5 Q9UNA0 1/20 0.34
MGAM O43451 1/20 0.34
GAA P10253 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
CNR1 P21554 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4983724 0.84 ALDH1A1 (0.41) AKR1B1POLBALDH1A1MGAMGAA
SCHEMBL4979426 0.83 CNR1 (0.51) AKR1B1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL4979166 0.81 CYP1A2 (0.39) AKR1B1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL4254388 0.80 AKR1B1 (0.41) AKR1B1POLBSMN1; SMN2ALDH1A1CNR1
SCHEMBL4974510 0.79 CNR1 (0.49) AKR1B1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL3953441 0.76 CYP1A2 (0.40) AKR1B1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL4979296 0.74 AKR1B1 (0.41) AKR1B1CYP1A2CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL4979616 0.74 KMT2A (0.37) AKR1B1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL4979964 0.73 CYP1A2 (0.42) AKR1B1CYP1A2POLBCYP3A4CYP2C19
SCHEMBL4976844 0.73 KMT2A (0.38) AKR1B1CYP1A2POLBCYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984374-A1 USE OF SPIRO Ý IMIDAZOLIDINE-4, 3'-INDOLE¨2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 AstraZeneca AB (SE) 2008-10-29 EP claimed
WO-2007091946-A1 USE OF SPIRO [ IMIDAZOLIDINE-4, 3'-INDOLE] 2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 ASTRAZENECA AB (SE) 2007-08-16 WO claimed